Key statistics
On Wednesday, RetinalGenix Technologies Inc (RTGN:QBB) closed at 3.20, 0.00% above its 52-week low of 3.20, set on Nov 05, 2025.
52-week range
| Open | 3.20 |
|---|---|
| High | 3.20 |
| Low | 3.20 |
| Bid | -- |
| Offer | -- |
| Previous close | 3.20 |
| Average volume | -- |
|---|---|
| Shares outstanding | 18.60m |
| Free float | 5.93m |
| P/E (TTM) | -- |
| Market cap | 59.54m USD |
| EPS (TTM) | -0.1455 USD |
Data delayed at least 15 minutes, as of Nov 05 2025 17:04 GMT.
More ▼
Announcements
- RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
- RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO
- RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
- RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
- RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
- RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening
- RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives
- RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
- RetinalGenix Technologies to Participate at the 37th Annual Roth Conference
- RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
More ▼
